anecortave acetate has been researched along with triamcinolone acetonide in 7 studies
| Studies (anecortave acetate) | Trials (anecortave acetate) | Recent Studies (post-2010) (anecortave acetate) | Studies (triamcinolone acetonide) | Trials (triamcinolone acetonide) | Recent Studies (post-2010) (triamcinolone acetonide) |
|---|---|---|---|---|---|
| 68 | 9 | 6 | 6,188 | 1,017 | 1,609 |
| Protein | Taxonomy | anecortave acetate (IC50) | triamcinolone acetonide (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.0044 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0044 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.0044 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0044 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0044 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandello, F; Chakravarthy, U; Chong, V; Creuzot-Garcher, C; Dimitrakos, SA; Korobelnik, JF; Larsen, M; Monés, J; Pauleikhoff, D; Pournaras, CJ; Soubrane, G; Staurenghi, G; Virgili, G; Wolf, S | 1 |
| Bienias, W; Nowak, JZ | 1 |
| Geltzer, A; Turalba, A; Vedula, SS | 2 |
| El Filali, M; Homminga, I; Jager, MJ; Maat, W; van der Velden, PA | 1 |
| Callanan, DG; Defaller, J; Robin, AL; Sjaarda, RN; Suan, EP | 1 |
3 review(s) available for anecortave acetate and triamcinolone acetonide
| Article | Year |
|---|---|
[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Bevacizumab; Humans; Lipofuscin; Macular Degeneration; Neovascularization, Pathologic; Photochemotherapy; Pregnadienediols; Ranibizumab; Retinal Drusen; Triamcinolone Acetonide | 2007 |
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide | 2007 |
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide | 2013 |
4 other study(ies) available for anecortave acetate and triamcinolone acetonide
| Article | Year |
|---|---|
Evolving European guidance on the medical management of neovascular age related macular degeneration.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Evidence-Based Medicine; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Ranibizumab; Treatment Outcome; Triamcinolone Acetonide | 2006 |
[Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Macular Degeneration; Ophthalmology; Photochemotherapy; Porphyrins; Pregnadienediols; Ranibizumab; Societies, Medical; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin | 2007 |
Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.
Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Eye Proteins; Humans; Melanoma; Nerve Growth Factors; Pregnadienediols; Serpins; Thrombospondin 1; Triamcinolone Acetonide; Uveal Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Delayed-Action Preparations; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Pregnadienediols; Prospective Studies; Retinal Diseases; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2009 |